Spain· ES:86063
ERWINASE 10.000 UI POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION
A medicinal product containing crisantaspasa, registered in Spain by Porton Biopharma Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- crisantaspasa
- Manufacturer
- Porton Biopharma Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Crisantaspasa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- DenmarkErwinasePorton Biopharma Limited
- BelgiumEnrylaze 10 mg/0.5 mlJazz Pharmaceuticals Ireland
- GermanyErwinasePorton Biopharma Limited
- FranceENRYLAZE 10 mg/0,5 mL, solution injectable/pour perfusionJAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE)
- IrelandEnrylaze 10 mg/0.5 mL solution for injection/infusion.Jazz Pharmaceuticals Ireland Limited
- NetherlandsEnrylaze 10 mg/0,5 ml oplossing voor injectie/infusieJazz Pharmaceuticals Ireland Ltd.
- NorwayErwinasePorton Biopharma Limided
- PolandEnrylazeJazz Pharmaceuticals Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Erwinase
- Germany · Erwinase
- Denmark · Erwinase
- Finland · Erwinase
- France · Erwinase
- United Kingdom (Northern Ireland) · Erwinase
- Ireland · Erwinase
- Netherlands · Erwinase
- Norway · Erwinase
- Portugal · Erwinase
- Sweden · Erwinase
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7adf4ab0-22d3-49e0-b657-a9d5ed3ff19d GET /v1/drugs/7adf4ab0-22d3-49e0-b657-a9d5ed3ff19d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1633452286000}",
"nregistro": "86063",
"substance": "crisantaspasa"
}See everything about crisantaspasa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.